InnoCare Pharma Limited
HKEX:9969.HK
6.85 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 8,224.596 | 8,697.927 | 5,928.716 | 3,969.64 | 2,291.773 | 1,876.618 | 36.874 |
| Short Term Investments
| -0 | 313.29 | 317.059 | 0 | 80.347 | 169.054 | 10.023 |
| Cash and Short Term Investments
| 8,224.596 | 9,011.217 | 6,245.775 | 3,969.64 | 2,372.12 | 2,045.672 | 46.897 |
| Net Receivables
| 276.378 | -102.269 | 145.078 | 120.675 | 0.037 | 0.044 | 0 |
| Inventory
| 119.095 | 65.322 | 9.918 | 1.878 | -80.347 | -169.054 | 0 |
| Other Current Assets
| 82.715 | 325.438 | 16.34 | 0.04 | 116.937 | 17.832 | 6.678 |
| Total Current Assets
| 8,765.323 | 9,299.708 | 6,417.111 | 4,092.233 | 2,408.747 | 2,063.504 | 53.575 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 1,089.039 | 952.213 | 502.366 | 329.353 | 58.424 | 17.961 | 12.078 |
| Goodwill
| 3.125 | 3.125 | 3.125 | 3.125 | 3.125 | 3.125 | 3.125 |
| Intangible Assets
| 39.007 | 41.305 | 139.446 | 111.84 | 113.377 | 114.084 | 36.58 |
| Goodwill and Intangible Assets
| 42.132 | 44.43 | 142.571 | 114.965 | 116.502 | 117.209 | 39.705 |
| Long Term Investments
| 5.66 | -301.578 | 9.039 | 1.159 | -79.188 | -167.895 | -8.86 |
| Tax Assets
| 9.776 | 301.578 | 275.493 | -1.159 | 80.347 | 169.054 | 10.023 |
| Other Non-Current Assets
| 7.199 | 24.807 | 50.951 | 1.159 | 30.861 | 1.326 | 0.88 |
| Total Non-Current Assets
| 1,153.806 | 1,021.45 | 980.42 | 445.477 | 206.946 | 137.655 | 53.826 |
| Total Assets
| 9,919.129 | 10,321.158 | 7,397.531 | 4,537.71 | 2,615.693 | 2,201.159 | 107.401 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 134.905 | 118.597 | 84.602 | 5.52 | 8.197 | 2.193 | 2.958 |
| Short Term Debt
| 1,279.364 | 1,217.28 | 20.336 | 6.833 | 15.302 | 64.609 | 79.132 |
| Tax Payables
| 15.253 | 32.58 | 37.36 | 1.401 | 0.529 | 0.575 | 0.217 |
| Deferred Revenue
| 203.389 | 0 | 0 | 0 | 0 | 0.575 | 0.217 |
| Other Current Liabilities
| 476.336 | 739.551 | 224.364 | 92.1 | 42.173 | 4.912 | 23.103 |
| Total Current Liabilities
| 2,093.994 | 2,075.428 | 329.302 | 104.453 | 65.672 | 72.289 | 105.41 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 69.947 | 35.439 | 1,248.006 | 1,166.715 | 1,120.57 | 965.06 | 57.283 |
| Deferred Revenue Non-Current
| 268.906 | 278.203 | 123.611 | 100 | 157.389 | 61.398 | 0.42 |
| Deferred Tax Liabilities Non-Current
| 23.797 | 0 | 0 | 6.036 | 6.036 | 6.036 | 6.036 |
| Other Non-Current Liabilities
| 281.78 | 287.761 | 37.693 | 0 | 4,213.772 | 1,934.75 | 330.316 |
| Total Non-Current Liabilities
| 644.43 | 601.403 | 1,409.31 | 1,272.751 | 5,497.767 | 2,967.244 | 394.055 |
| Total Liabilities
| 2,738.424 | 2,676.831 | 1,738.612 | 1,377.204 | 5,563.439 | 3,039.533 | 499.465 |
| Equity: | |||||||
| Preferred Stock
| 0 | 36.312 | 230.851 | 95.052 | 0 | 939.007 | 389.057 |
| Common Stock
| 0.023 | 0.023 | 0.019 | 0.016 | 0.004 | 0.003 | 0.003 |
| Retained Earnings
| -5,054.191 | -4,422.928 | -3,536.335 | -3,544.188 | -3,080.395 | -939.007 | -389.057 |
| Accumulated Other Comprehensive Income/Loss
| 77.232 | -36.312 | -230.851 | -95.052 | 66.34 | -1.985 | -0.907 |
| Other Total Stockholders Equity
| 12,124.784 | 12,020.006 | 9,140.875 | 6,648.184 | 9.341 | -902.319 | -391.16 |
| Total Shareholders Equity
| 7,147.848 | 7,597.101 | 5,604.559 | 3,104.012 | -3,004.71 | -904.301 | -392.064 |
| Total Equity
| 7,180.705 | 7,644.327 | 5,658.919 | 3,160.506 | -2,947.746 | -838.374 | -392.064 |
| Total Liabilities & Shareholders Equity
| 9,919.129 | 10,321.158 | 7,397.531 | 4,537.71 | 2,615.693 | 2,201.159 | 107.401 |